Business
Premier Biomedical Announces $1.6mil Financing – Consolidates Funding Needs Through 2016
Premier Biomedical Announces $1.6mil Financing – Consolidates Funding Needs Through 2016.
About this update from Premier Biomedical Inc
[{"type":"text","content":"\n \n Premier Biomedical, Inc. (OTCQB: \n \"BIEI\") a biotech research company focused on discovering, \n developing, and commercializing medical treatments for a wide range of \n diseases in humans, including innovative therapies for breast cancer, \n announced today that they have consolidated and secured financing via a \n convertible note with restricted shares per tranche to fund their \n aggressive development plans through 2016, when revenues from world-wide \n joint ventures are anticipated to meet their ongoing financial needs. \n The financing arrangement allows Premier to remove old debt from its \n books and consolidate financing with a single funding source, while \n meeting its medium-term cash needs.\n \n \n William A. Hartman, President and CEO of Premier stated, “We are pleased \n to be able to get our financing needs for the coming year behind us via \n non-toxic means so we can concentrate on moving the company forward, \n growing our technology, and expanding our reach globally, facilitating \n revenue generation and mid-term self-funding.”\n \n \n Chardan Capital Markets acted as placement agent for this transaction.\n \n \n Contact William Hartman at (724) 633-7033, [email protected].\n \n \n About Premier Biomedical, Inc.\n \n \n Premier \n Biomedical, Inc. (OTCQB: BIEI) \n is a research-based company that intends to discover and develop medical \n treatments for a wide range of diseases in humans. Premier has obtained, \n via license agreements, the technology behind multiple provisional \n patents in the United States and a PCT Europe National Patent. Founded \n in 2010, Premier has partnered with the Department of Defense with \n Center of Expertise at the William Beaumont Army Medical Center. The \n company's R&D efforts are centered in El Paso, TX. The Company is a \n fully-reporting issuer whose common stock trades on the OTCQB \n marketplace maintained by OTC Markets Group, Inc. under the ticker \n symbol \"BIEI\".\n \n \n For more information, visit our website http://www.premierbiomedical.com/\n \n \n Safe Harbor Notice\n \n \n Certain statements contained herein are “forward-looking statements” (as \n defined in the Private Securities Litigation Reform Act of 1995). \n Premier Biomedical, Inc. cautions that statements, and assumptions made \n in this news releas...